|
|
 |
|
| About INAGEN Research and development is the key at INAGEN. We work highly focused to produce the first in class drug to a market with increasing demands for new and better antiviral drugs. INAGEN has created a novel method of developing new forms of therapies against viral diseases. The technology utilizes a “self targeting” capability that occurs in the natural defence mechanism of the specific disease to target and kill infected cells. The platform technology can be developed for numerous infectious diseases. INAGEN is a biotech start up company localized at Risų-DTU in Roskilde.
For further information regarding INAGEN please contakt Thomas Kledal, CEO; Phone: +45 4677 5938, Mobile: +45 28772749; email: tk@inagen.com |
|
